Elliptic Fourier analysis of megakaryocyte nuclei in chronic myeloproliferative disorders.
Elliptic Fourier analysis was applied to megakaryocyte nuclei in bone marrow biopsies from 15 patients with chronic myelocytic leukemia with megakaryocyte predominance and from 15 patients with chronic megakaryocytic granulocytic myelosis. To assess the reliability of this procedure, the biopsies were evaluated also by the semiautomatic measurement of nuclear area and form factor, and both methods were compared with respect to the degree of morphologic differences obtained between these two types of chronic myeloproliferative disorders (CMPDs). Discriminant analysis revealed correct reclassification of all cases both for elliptic Fourier analysis and for semiautomatic planimetry, whereas discriminant scores were much higher for Fourier analysis. Thus, simple planimetric features such as nuclear area and form factor, in contrast to Fourier analysis, are not able to detect the full degree of morphologic differences between megakaryocyte nuclei in different CMPDs. Elliptic Fourier analysis therefore seems to be a useful procedure for the accurate description of such complicated structures as megakaryocyte nuclei in CMPD.
Nafe
R
R
Institute of Pathology, Hannover Medical School, Germany.
Kaloutsi
V
V
Choritz
H
H
Georgii
A
A
D000704:Analysis of Variance; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D002467:Cell Nucleus / Q000648:ultrastructure*; D016002:Discriminant Analysis; D005583:Fourier Analysis; D006801:Humans; D007091:Image Processing, Computer-Assisted; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000473:pathology; D008533:Megakaryocytes / Q000648:ultrastructure*; D008853:Microscopy; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000473:pathology*; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000473:pathology